Review

PD-1, PD-L1 mechanism and cancer treatment

Aslı Babayakalı, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.019
2032 1874

Neurotransmitters and hair loss

Aylin Kayaaltı, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.020
3090 11613

RIPK1 and obesity-induced inflammation

Aslı Melike Ekmekçi, Fehmi Balandi, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.021
2245 1627

Terazosin and neuroprotection

Ayşe Yürekli, Atakan Ölçenoğlu, Manolya Yıldız, Begüm Arda, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.022
3550 2041

Tumor markers and clinical use

Burak Akverdi, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.023
4462 6072

Alkaliptosis: A new strategy for cancer therapy

Beyza Emine Kılınç, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.024
2895 2289

Subgenual anterior cingulate cortex and psychiatric disorders

Berfin Sıla Akdoğdu, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.025
3456 1601

Bone marrow transplantation use on treatment solid tumors

İlayda Üzümcü, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.026
2134 1880

Superparamagnetic iron oxide nanoparticles use in the temporal lobe epilepsy model

Özge Çağlar, Elif Özyılmaz, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.027
2052 1662

Effect of mitochondrial dysfunction and oxidative stress on the pathogenesis of autism spectrum disorders

Umut Yücel, İrem Kahramanoğlu, İlknur Altuntaş, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.028
4524 2088

Cancer cells and alpha-ketoglutarate

Yalda Sadeghian, İlayda Üzümcü, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.029
2912 2550